CEFIXIME

CEFIXIME was reported 3061 times

CEFIXIME is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRACHYMETATARSIA 2 0.2857
1 LIVER IRON CONCENTRATION ABNORMAL 6 0.2400
2 TRACHEOBRONCHITIS BACTERIAL 6 0.2308
3 OROPHARYNGEAL GONOCOCCAL INFECTION 6 0.2222
4 BIOPSY COLON ABNORMAL 8 0.1250
5 NEONATAL HEPATOMEGALY 7 0.1250
6 MUSCULOSKELETAL FOREIGN BODY 3 0.1000
7 NEONATAL HYPOCALCAEMIA 7 0.0933
8 TONGUE DYSPLASIA 3 0.0909
9 VAGINAL FLATULENCE 22 0.0726
10 FOOD PROTEIN-INDUCED ENTEROCOLITIS SYNDROME 3 0.0714
11 GASTROENTERITIS STAPHYLOCOCCAL 11 0.0701
12 MUCOCUTANEOUS CANDIDIASIS 4 0.0430
13 ORAL PUSTULE 9 0.0386
14 NEONATAL BEHAVIOURAL SYNDROME 9 0.0294
15 GASTROINTESTINAL MUCOSA HYPERAEMIA 8 0.0270
16 FOETAL MACROSOMIA 7 0.0252
17 CARNITINE DEFICIENCY 4 0.0234
18 DYSBACTERIOSIS 5 0.0234
19 PH URINE INCREASED 4 0.0231
20 ATYPICAL MYCOBACTERIAL PNEUMONIA 3 0.0216
21 PNEUMONIA MYCOPLASMAL 16 0.0201
22 BODY HEIGHT ABNORMAL 2 0.0172
23 CANDIDA TEST POSITIVE 7 0.0167
24 NORMOCHROMIC ANAEMIA 3 0.0150
25 RETICULOCYTOSIS 3 0.0142
26 FEMALE GENITAL TRACT FISTULA 24 0.0140
27 POSITIVE AIRWAY PRESSURE THERAPY 4 0.0137
28 HEAT EXHAUSTION 11 0.0136
29 CONGENITAL UMBILICAL HERNIA 5 0.0134
30 FAMILIAL PERIODIC PARALYSIS 3 0.0132
31 DYSBIOSIS 10 0.0122
32 HYPOCAPNIA 5 0.0120
33 INCISION SITE DISCHARGE 3 0.0119
34 NEOVASCULARISATION 3 0.0114
35 NEONATAL RESPIRATORY DISTRESS 10 0.0106
36 BONE DEMINERALISATION 10 0.0094
37 RED BLOOD CELL SCHISTOCYTES PRESENT 3 0.0093
38 RADICULOPATHY 24 0.0091
39 MOANING 10 0.0088
40 TENOPLASTY 3 0.0086
41 RHINOCEREBRAL MUCORMYCOSIS 3 0.0086
42 PROCTITIS 24 0.0086
43 VULVOVAGINAL CANDIDIASIS 11 0.0081
44 CHLAMYDIAL INFECTION 6 0.0079
45 PHYSICAL EXAMINATION ABNORMAL 3 0.0078
46 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 4 0.0078
47 CLOSTRIDIUM TEST POSITIVE 16 0.0072
48 MYOFASCIAL PAIN SYNDROME 5 0.0070
49 BONE DEVELOPMENT ABNORMAL 2 0.0070
50 NECK DEFORMITY 3 0.0068
51 CHRONIC SINUSITIS 25 0.0067
52 HYDROCELE 7 0.0066
53 VAGINAL INFECTION 29 0.0062
54 LEUKOCYTURIA 5 0.0061
55 HYPOTONIA NEONATAL 9 0.0058
56 PNEUMONIA KLEBSIELLA 10 0.0054
57 ENTEROCOLITIS INFECTIOUS 5 0.0054
58 APRAXIA 8 0.0054
59 MULTIPLE DRUG THERAPY 4 0.0053
60 ENDOCARDITIS BACTERIAL 4 0.0051
61 DISCHARGE 7 0.0050
62 MALIGNANT MELANOMA IN SITU 6 0.0048
63 MONOCYTOSIS 3 0.0048
64 HEPATIC ENZYME ABNORMAL 24 0.0048
65 SERUM SICKNESS-LIKE REACTION 3 0.0048
66 MACULAR DEGENERATION 56 0.0047
67 CHONDROCALCINOSIS 3 0.0046
68 LARGE FOR DATES BABY 4 0.0045
69 VANISHING BILE DUCT SYNDROME 5 0.0045
70 BLOOD ALKALINE PHOSPHATASE DECREASED 4 0.0042
71 VISCERAL LEISHMANIASIS 3 0.0042
72 PURULENCE 8 0.0041
73 PSEUDOMEMBRANOUS COLITIS 9 0.0040
74 GINGIVAL ABSCESS 3 0.0040
75 TRANSITIONAL CELL CARCINOMA 5 0.0039
76 PLASMA CELL MYELOMA REFRACTORY 5 0.0037
77 IIIRD NERVE PARALYSIS 3 0.0037
78 COSTOCHONDRITIS 6 0.0037
79 GASTROENTERITIS SALMONELLA 3 0.0036
80 OLIGOHYDRAMNIOS 12 0.0036
81 BACTERIURIA 2 0.0035
82 AMBLYOPIA 2 0.0034
83 ADENOMYOSIS 2 0.0034
84 PNEUMONIA PNEUMOCOCCAL 5 0.0034
85 MAGNETIC RESONANCE IMAGING ABNORMAL 4 0.0033
86 CLOSTRIDIUM DIFFICILE COLITIS 35 0.0033
87 PALATAL OEDEMA 4 0.0032
88 BLOOD IRON INCREASED 6 0.0032
89 NEUTROPHIL PERCENTAGE INCREASED 4 0.0032
90 SLOW RESPONSE TO STIMULI 4 0.0031
91 HAEMOPHILUS INFECTION 3 0.0031
92 PYELONEPHRITIS ACUTE 6 0.0031
93 LYMPHOCYTE PERCENTAGE DECREASED 4 0.0030
94 PULMONARY CONGESTION 39 0.0030
95 TOOTH ABSCESS 30 0.0029
96 BREAST ABSCESS 3 0.0029
97 TONGUE COATED 5 0.0029
98 SINUSITIS BACTERIAL 3 0.0028
99 CONNECTIVE TISSUE DISORDER 4 0.0028
100 ORCHITIS 3 0.0028
101 PNEUMONIA STREPTOCOCCAL 3 0.0027
102 TOXIC EPIDERMAL NECROLYSIS 41 0.0027
103 AMINO ACID LEVEL INCREASED 2 0.0027
104 NEOPLASM RECURRENCE 9 0.0027
105 SECRETION DISCHARGE 33 0.0026
106 FOETAL GROWTH RESTRICTION 16 0.0026
107 PHOBIA 3 0.0026
108 CONJUNCTIVAL HAEMORRHAGE 10 0.0026
109 MENISCUS INJURY 16 0.0026
110 ACUTE PRERENAL FAILURE 3 0.0026
111 LUMBAR RADICULOPATHY 3 0.0026
112 EPIDIDYMITIS 3 0.0026
113 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 20 0.0026
114 LIP ULCERATION 3 0.0026
115 APLASIA 5 0.0026
116 BILE DUCT STENOSIS 3 0.0025
117 BASAL GANGLIA HAEMORRHAGE 2 0.0025
118 HYPOGLYCAEMIC COMA 7 0.0024
119 MEAN CELL HAEMOGLOBIN INCREASED 4 0.0024
120 LINEAR IGA DISEASE 4 0.0024
121 HEPATIC NECROSIS 9 0.0024
122 URINARY TRACT INFECTION BACTERIAL 6 0.0024
123 ORAL CANDIDIASIS 31 0.0024
124 LIP HAEMORRHAGE 3 0.0024
125 PRE-ECLAMPSIA 11 0.0023
126 PULMONARY MASS 34 0.0023
127 VAGINAL DISCHARGE 23 0.0023
128 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
129 WHITE BLOOD CELLS URINE POSITIVE 4 0.0021
130 FEBRILE BONE MARROW APLASIA 9 0.0021
131 PNEUMATOSIS INTESTINALIS 6 0.0021
132 NEPHRITIS 7 0.0021
133 SPEECH DISORDER DEVELOPMENTAL 6 0.0021
134 ANKYLOSING SPONDYLITIS 27 0.0020
135 OVERWEIGHT 11 0.0020
136 NORMOCYTIC ANAEMIA 3 0.0020
137 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 4 0.0020
138 ORAL MUCOSAL EXFOLIATION 3 0.0020
139 CLOSTRIDIUM DIFFICILE INFECTION 43 0.0020
140 BENIGN BREAST NEOPLASM 2 0.0020
141 SEDATION COMPLICATION 5 0.0020
142 PRODUCT ADMINISTRATION INTERRUPTED 15 0.0019
143 MEGACOLON 3 0.0019
144 IMMUNE-MEDIATED ENTEROCOLITIS 7 0.0019
145 RHINITIS 15 0.0019
146 SKULL FRACTURE 3 0.0018
147 SALMONELLOSIS 3 0.0018
148 BILIARY DYSKINESIA 3 0.0018
149 FIXED ERUPTION 3 0.0017
150 PARAESTHESIA ORAL 25 0.0017
151 LUMBAR SPINAL STENOSIS 5 0.0017
152 HYPERURICAEMIA 7 0.0017
153 VARICELLA 4 0.0017
154 PULSE ABNORMAL 4 0.0017
155 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
156 BRONCHITIS CHRONIC 4 0.0016
157 ISCHAEMIC CARDIOMYOPATHY 5 0.0016
158 BLOOD PRESSURE SYSTOLIC ABNORMAL 4 0.0016
159 MULTIPLE-DRUG RESISTANCE 5 0.0016
160 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
161 EXPOSURE VIA INGESTION 4 0.0016
162 ESCHERICHIA INFECTION 13 0.0016
163 RHINOVIRUS INFECTION 6 0.0015
164 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
165 STEVENS-JOHNSON SYNDROME 33 0.0015
166 MUSCLE CONTRACTURE 3 0.0015
167 SKIN LESION 40 0.0015
168 TENDON PAIN 11 0.0015
169 PRE-EXISTING CONDITION IMPROVED 9 0.0014
170 BODY TEMPERATURE FLUCTUATION 3 0.0014
171 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
172 NEONATAL RESPIRATORY DISTRESS SYNDROME 5 0.0014
173 AUDITORY DISORDER 2 0.0014
174 ENTERITIS 9 0.0014
175 HEART VALVE INCOMPETENCE 4 0.0014
176 INFUSION SITE BRUISING 3 0.0014
177 SPUTUM INCREASED 3 0.0014
178 ADENOVIRUS INFECTION 4 0.0014
179 CEREBELLAR SYNDROME 3 0.0014
180 PATHOGEN RESISTANCE 12 0.0013
181 LUMBAR VERTEBRAL FRACTURE 6 0.0013
182 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
183 RASH MACULO-PAPULAR 29 0.0013
184 CHOLESTASIS 25 0.0013
185 TUBULOINTERSTITIAL NEPHRITIS 24 0.0013
186 BACTERIAL VAGINOSIS 2 0.0013
187 FEBRILE NEUTROPENIA 83 0.0012
188 WEIGHT ABNORMAL 3 0.0012
189 IMPAIRED GASTRIC EMPTYING 17 0.0012
190 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
191 HAEMATOLOGICAL INFECTION 3 0.0012
192 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
193 ENTEROCOLITIS 7 0.0012
194 SPINAL STENOSIS 5 0.0012
195 OTITIS MEDIA 4 0.0012
196 INFLAMMATORY MARKER INCREASED 6 0.0012
197 ANTIBODY TEST POSITIVE 2 0.0012
198 FREQUENT BOWEL MOVEMENTS 32 0.0012
199 LIP OEDEMA 5 0.0012
200 ANHEDONIA 31 0.0012
201 ERYTHEMA MULTIFORME 11 0.0012
202 INCREASED BRONCHIAL SECRETION 3 0.0012
203 APHTHOUS ULCER 9 0.0012
204 LARGE INTESTINE POLYP 8 0.0012
205 PYELONEPHRITIS 10 0.0012
206 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
207 ERYTHEMA NODOSUM 4 0.0011
208 JOINT DISLOCATION 12 0.0011
209 LOW BIRTH WEIGHT BABY 9 0.0011
210 PREMATURE BABY 34 0.0011
211 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 29 0.0011
212 AREFLEXIA 3 0.0011
213 ABDOMINAL MASS 3 0.0011
214 BLOOD SODIUM INCREASED 3 0.0011
215 PSORIATIC ARTHROPATHY 45 0.0011
216 COLITIS 42 0.0011
217 MONOCYTE COUNT INCREASED 4 0.0011
218 RENAL FUNCTION TEST ABNORMAL 5 0.0011
219 SNORING 4 0.0011
220 BILE DUCT OBSTRUCTION 2 0.0011
221 SKIN ATROPHY 6 0.0010
222 TENDONITIS 16 0.0010
223 SPINAL CORD COMPRESSION 4 0.0010
224 NECK INJURY 3 0.0010
225 GROWTH RETARDATION 3 0.0010
226 RESPIRATORY RATE INCREASED 9 0.0010
227 CREPITATIONS 3 0.0010
228 MOVEMENT DISORDER 32 0.0010
229 TOXIC SKIN ERUPTION 10 0.0010
230 ENURESIS 4 0.0010
231 ECONOMIC PROBLEM 15 0.0010
232 AGRANULOCYTOSIS 18 0.0010
233 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
234 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
235 BLOOD LACTIC ACID INCREASED 5 0.0009
236 POLYARTHRITIS 5 0.0009
237 PNEUMONIA VIRAL 3 0.0009
238 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
239 ANAL FISSURE 5 0.0009
240 ORTHOSTATIC HYPOTENSION 16 0.0009
241 BODY TEMPERATURE DECREASED 9 0.0009
242 EOSINOPHILIA 16 0.0009
243 DEAFNESS NEUROSENSORY 3 0.0009
244 GASTROINTESTINAL PAIN 10 0.0009
245 PARALYSIS 13 0.0009
246 PROCEDURAL PAIN 25 0.0009
247 PLANTAR FASCIITIS 3 0.0009
248 TORSADE DE POINTES 7 0.0009
249 HYPOTHERMIA 9 0.0009
250 TONGUE ULCERATION 3 0.0009
251 CLOSTRIDIAL INFECTION 3 0.0009
252 AUTOIMMUNE HAEMOLYTIC ANAEMIA 3 0.0009
253 SEPTIC SHOCK 38 0.0009
254 LEFT VENTRICULAR FAILURE 3 0.0009
255 DEPRESSION SUICIDAL 3 0.0009
256 HYPERTRANSAMINASAEMIA 6 0.0009
257 EAR PRURITUS 3 0.0009
258 TYPE I HYPERSENSITIVITY 3 0.0009
259 PANIC ATTACK 31 0.0008
260 JAUNDICE CHOLESTATIC 3 0.0008
261 FACIAL PARESIS 3 0.0008
262 HEPATOCELLULAR INJURY 12 0.0008
263 BACTERAEMIA 10 0.0008
264 PLEURISY 5 0.0008
265 HAEMATOTOXICITY 8 0.0008
266 PYODERMA GANGRENOSUM 3 0.0008
267 FACE OEDEMA 14 0.0008
268 HEPATITIS CHOLESTATIC 5 0.0008
269 DERMATITIS BULLOUS 6 0.0008
270 THROMBOTIC MICROANGIOPATHY 8 0.0008
271 CYSTITIS 26 0.0008
272 FOOT OPERATION 4 0.0008
273 ORGANISING PNEUMONIA 4 0.0008
274 TENDON INJURY 3 0.0008
275 PHARYNGITIS 10 0.0008
276 INFUSION SITE EXTRAVASATION 5 0.0008
277 BLOOD CALCIUM DECREASED 9 0.0008
278 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
279 AUTOIMMUNE THYROIDITIS 3 0.0008
280 PURPURA 7 0.0008
281 NEPHROLITHIASIS 36 0.0008
282 HYPOTHYROIDISM 25 0.0008
283 NEUTROPHIL COUNT INCREASED 8 0.0008
284 HYPOKALAEMIA 36 0.0008
285 CACHEXIA 4 0.0008
286 HYPERBILIRUBINAEMIA 8 0.0008
287 HYPOALBUMINAEMIA 6 0.0008
288 TRANSAMINASES INCREASED 17 0.0008
289 NAIL DISCOLOURATION 3 0.0008
290 PNEUMONIA BACTERIAL 7 0.0008
291 HYPOGAMMAGLOBULINAEMIA 5 0.0008
292 PNEUMONIA FUNGAL 3 0.0008
293 TREATMENT FAILURE 63 0.0008
294 SNEEZING 17 0.0008
295 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
296 HAEMATOCHEZIA 41 0.0007
297 FIBROMYALGIA 18 0.0007
298 EYE MOVEMENT DISORDER 5 0.0007
299 FAECALOMA 4 0.0007
300 OSTEOPENIA 11 0.0007
301 RECTAL HAEMORRHAGE 31 0.0007
302 GASTROINTESTINAL PERFORATION 3 0.0007
303 STREPTOCOCCAL INFECTION 4 0.0007
304 NECROSIS 4 0.0007
305 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
306 HEPATOMEGALY 7 0.0007
307 MOUTH ULCERATION 15 0.0007
308 SKIN PLAQUE 6 0.0007
309 HEPATIC CYTOLYSIS 9 0.0007
310 ABSCESS LIMB 3 0.0007
311 NEUTROPHILIA 4 0.0007
312 ORAL DISORDER 5 0.0007
313 DRUG ERUPTION 12 0.0007
314 ILEUS PARALYTIC 3 0.0007
315 BLOOD CULTURE POSITIVE 2 0.0007
316 KIDNEY INFECTION 13 0.0007
317 NEOPLASM PROGRESSION 23 0.0007
318 TROPONIN INCREASED 5 0.0007
319 IMMUNE THROMBOCYTOPENIA 3 0.0007
320 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
321 NERVE COMPRESSION 6 0.0006
322 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
323 THERAPY PARTIAL RESPONDER 10 0.0006
324 FEEDING DISORDER 13 0.0006
325 FOOT DEFORMITY 7 0.0006
326 ENTEROCOCCAL INFECTION 3 0.0006
327 HEPATITIS ACUTE 4 0.0006
328 MUCOSAL INFLAMMATION 16 0.0006
329 POLYURIA 5 0.0006
330 OSTEOPOROSIS 25 0.0006
331 LIGAMENT SPRAIN 6 0.0006
332 MENSTRUAL DISORDER 5 0.0006
333 END STAGE RENAL DISEASE 11 0.0006
334 EOSINOPHIL COUNT INCREASED 5 0.0006
335 DERMATITIS EXFOLIATIVE 3 0.0006
336 VEIN DISORDER 3 0.0006
337 ANXIETY DISORDER 2 0.0006
338 LIVE BIRTH 5 0.0006
339 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
340 PRODUCT SOLUBILITY ABNORMAL 3 0.0006
341 SENSATION OF FOREIGN BODY 5 0.0006
342 TACHYPNOEA 8 0.0006
343 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
344 EAR DISCOMFORT 6 0.0006
345 UPPER RESPIRATORY TRACT INFECTION 27 0.0006
346 HEPATOTOXICITY 13 0.0006
347 ONYCHOCLASIS 4 0.0006
348 POOR VENOUS ACCESS 6 0.0006
349 SLEEP APNOEA SYNDROME 11 0.0006
350 TONSILLITIS 3 0.0006
351 CARDIOMEGALY 7 0.0006
352 NYSTAGMUS 3 0.0006
353 PHARYNGOLARYNGEAL PAIN 3 0.0006
354 THERMAL BURN 4 0.0006
355 BRONCHOSPASM 8 0.0006
356 FACIAL PAIN 5 0.0006
357 COLITIS ULCERATIVE 25 0.0006
358 POISONING 7 0.0006
359 ANAL ABSCESS 3 0.0006
360 NECK PAIN 31 0.0006
361 CHEILITIS 3 0.0006
362 HYDROCEPHALUS 3 0.0006
363 FAECES SOFT 4 0.0005
364 MOUTH HAEMORRHAGE 4 0.0005
365 HYPERKERATOSIS 3 0.0005
366 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
367 ANGIOEDEMA 24 0.0005
368 DENTAL CARIES 6 0.0005
369 DIARRHOEA HAEMORRHAGIC 5 0.0005
370 JOINT STIFFNESS 14 0.0005
371 PERIORBITAL SWELLING 3 0.0005
372 PEMPHIGOID 4 0.0005
373 DRUG INTOLERANCE 51 0.0005
374 PERONEAL NERVE PALSY 3 0.0005
375 PROTEINURIA 10 0.0005
376 C-REACTIVE PROTEIN INCREASED 19 0.0005
377 NEUTROPENIA 71 0.0005
378 DEVICE RELATED INFECTION 8 0.0005
379 ANKLE FRACTURE 8 0.0005
380 SKIN WARM 3 0.0005
381 POST PROCEDURAL HAEMORRHAGE 6 0.0005
382 PNEUMONITIS 14 0.0005
383 COVID-19 90 0.0005
384 VITAMIN D DEFICIENCY 5 0.0005
385 HEART RATE DECREASED 18 0.0005
386 BRAIN FOG 8 0.0005
387 PYREXIA 175 0.0005
388 ABDOMINAL PAIN 117 0.0005
389 PRODUCTIVE COUGH 24 0.0005
390 ODYNOPHAGIA 3 0.0005
391 ENDOPHTHALMITIS 3 0.0005
392 INFUSION RELATED REACTION 33 0.0005
393 HEPATIC FAILURE 15 0.0005
394 INTENTIONAL SELF-INJURY 10 0.0005
395 RESTLESS LEGS SYNDROME 9 0.0005
396 SPINAL OPERATION 6 0.0005
397 JAUNDICE 13 0.0005
398 THERAPEUTIC RESPONSE SHORTENED 16 0.0005
399 MATERNAL EXPOSURE DURING PREGNANCY 43 0.0005
400 VIRAL INFECTION 16 0.0005
401 TENDERNESS 5 0.0005
402 DRUG-INDUCED LIVER INJURY 15 0.0005
403 WEIGHT FLUCTUATION 5 0.0005
404 DYSPNOEA EXERTIONAL 18 0.0005
405 DYSPEPSIA 47 0.0005
406 ANAEMIA 91 0.0005
407 INFUSION SITE SWELLING 3 0.0005
408 INFUSION SITE ERYTHEMA 4 0.0005
409 INTENTIONAL PRODUCT USE ISSUE 41 0.0005
410 VITAMIN D DECREASED 4 0.0005
411 ROTATOR CUFF SYNDROME 6 0.0005
412 HYPERGLYCAEMIA 17 0.0005
413 PANCYTOPENIA 26 0.0005
414 RHINORRHOEA 30 0.0005
415 BLOOD MAGNESIUM DECREASED 4 0.0005
416 DECREASED ACTIVITY 5 0.0005
417 EAR PAIN 9 0.0005
418 HAEMORRHOIDS 9 0.0005
419 RESPIRATORY TRACT INFECTION 12 0.0005
420 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
421 INTENTIONAL DOSE OMISSION 13 0.0005
422 SPINAL OSTEOARTHRITIS 4 0.0005
423 STAPHYLOCOCCAL INFECTION 15 0.0005
424 SARS-COV-2 TEST POSITIVE 6 0.0005
425 LYMPHOCYTE COUNT DECREASED 8 0.0005
426 ABDOMINAL ABSCESS 2 0.0005
427 APPETITE DISORDER 3 0.0005
428 ADVERSE REACTION 6 0.0005
429 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
430 EAR INFECTION 12 0.0005
431 ACUTE KIDNEY INJURY 69 0.0005
432 POST-TRAUMATIC STRESS DISORDER 3 0.0004
433 GASTROINTESTINAL INFECTION 4 0.0004
434 FISTULA 5 0.0004
435 POSTOPERATIVE WOUND INFECTION 3 0.0004
436 SINUS CONGESTION 6 0.0004
437 FOETAL EXPOSURE DURING PREGNANCY 36 0.0004
438 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
439 LEUKOCYTOSIS 8 0.0004
440 PNEUMOTHORAX 7 0.0004
441 ULCER 7 0.0004
442 LEUKOPENIA 22 0.0004
443 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0004
444 RETINAL DETACHMENT 4 0.0004
445 JOINT EFFUSION 3 0.0004
446 CHEST PAIN 80 0.0004
447 ELECTROLYTE IMBALANCE 5 0.0004
448 EYELID OEDEMA 5 0.0004
449 DEFAECATION URGENCY 3 0.0004
450 SPINAL PAIN 5 0.0004
451 APPLICATION SITE REACTION 3 0.0004
452 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
453 PAPULE 3 0.0004
454 HAND FRACTURE 3 0.0004
455 EATING DISORDER 9 0.0004
456 SPINAL DISORDER 4 0.0004
457 CONSTIPATION 92 0.0004
458 SPUTUM DISCOLOURED 4 0.0004
459 DISEASE RECURRENCE 20 0.0004
460 ACCIDENT 5 0.0004
461 ERYTHEMA 86 0.0004
462 IMPAIRED QUALITY OF LIFE 6 0.0004
463 ATELECTASIS 4 0.0004
464 BURSITIS 5 0.0004
465 RASH PUSTULAR 3 0.0004
466 GASTROENTERITIS 6 0.0004
467 MAJOR DEPRESSION 3 0.0004
468 BLOOD BILIRUBIN INCREASED 11 0.0004
469 HYPOPHOSPHATAEMIA 3 0.0004
470 ABDOMINAL TENDERNESS 2 0.0004
471 CHILLS 47 0.0004
472 HYPOTONIA 4 0.0004
473 RESPIRATORY DISTRESS 11 0.0004
474 PAROSMIA 3 0.0004
475 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 19 0.0004
476 ACIDOSIS 3 0.0004
477 HIP ARTHROPLASTY 6 0.0004
478 FUNGAL INFECTION 13 0.0004
479 LIMB DISCOMFORT 12 0.0004
480 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
481 DIPLOPIA 10 0.0004
482 CONDITION AGGRAVATED 117 0.0004
483 PULMONARY HAEMORRHAGE 3 0.0004
484 DYSURIA 14 0.0004
485 IMMUNE SYSTEM DISORDER 5 0.0004
486 FURUNCLE 3 0.0004
487 RESPIRATORY TRACT CONGESTION 6 0.0004
488 SEPSIS 42 0.0004
489 LOWER RESPIRATORY TRACT INFECTION 17 0.0004
490 OXYGEN SATURATION DECREASED 21 0.0004
491 POOR QUALITY SLEEP 8 0.0004
492 MUSCLE DISORDER 3 0.0004
493 OEDEMA 20 0.0004
494 SUBSTANCE ABUSE 3 0.0004
495 INFLAMMATION 19 0.0004
496 BACK INJURY 4 0.0004
497 BLOOD CREATININE INCREASED 24 0.0004
498 HYPERAESTHESIA 3 0.0004
499 CORONARY ARTERY OCCLUSION 5 0.0004
500 URINARY TRACT INFECTION 62 0.0004
501 PHOTOSENSITIVITY REACTION 6 0.0004
502 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
503 EMBOLISM 3 0.0004
504 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
505 THROMBOCYTOPENIA 40 0.0004
506 COMA 17 0.0004
507 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
508 CANDIDA INFECTION 6 0.0004
509 STATUS EPILEPTICUS 4 0.0004
510 SCAB 4 0.0004
511 HAEMATURIA 12 0.0004
512 MICTURITION URGENCY 4 0.0003
513 CHOLECYSTECTOMY 4 0.0003
514 TACHYCARDIA 31 0.0003
515 ANURIA 3 0.0003
516 CARDIAC MURMUR 3 0.0003
517 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
518 DEAFNESS 9 0.0003
519 SEDATION 9 0.0003
520 NEUTROPHIL COUNT DECREASED 14 0.0003
521 HEART RATE INCREASED 34 0.0003
522 NAIL DISORDER 3 0.0003
523 HYPERKALAEMIA 12 0.0003
524 GASTRITIS 9 0.0003
525 SINUSITIS 35 0.0003
526 OFF LABEL USE 299 0.0003
527 URTICARIA 57 0.0003
528 CHOLELITHIASIS 11 0.0003
529 IMMUNODEFICIENCY 5 0.0003
530 BLOOD PRESSURE FLUCTUATION 8 0.0003
531 BACK PAIN 77 0.0003
532 TOOTHACHE 6 0.0003
533 LIMB INJURY 9 0.0003
534 PALLOR 9 0.0003
535 HYPOGLYCAEMIA 16 0.0003
536 ADRENAL INSUFFICIENCY 4 0.0003
537 GAIT INABILITY 11 0.0003
538 PRESYNCOPE 8 0.0003
539 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 59 0.0003
540 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
541 UROSEPSIS 3 0.0003
542 GRAND MAL CONVULSION 3 0.0003
543 OROPHARYNGEAL PAIN 30 0.0003
544 GENERALISED OEDEMA 4 0.0003
545 DEHYDRATION 43 0.0003
546 DELUSION 5 0.0003
547 ILEUS 4 0.0003
548 MALAISE 141 0.0003
549 BRADYCARDIA 17 0.0003
550 FLANK PAIN 3 0.0003
551 BONE DENSITY DECREASED 10 0.0003
552 HYPOCALCAEMIA 6 0.0003
553 HYPOPHAGIA 8 0.0003
554 DISEASE PROGRESSION 37 0.0003
555 LOWER LIMB FRACTURE 6 0.0003
556 ACUTE RESPIRATORY FAILURE 6 0.0003
557 DRUG RESISTANCE 8 0.0003
558 BRONCHITIS 23 0.0003
559 CHROMATURIA 7 0.0003
560 DYSSTASIA 9 0.0003
561 PSORIASIS 40 0.0003
562 RENAL TUBULAR NECROSIS 3 0.0003
563 EXPOSURE DURING PREGNANCY 19 0.0003
564 EMOTIONAL DISTRESS 37 0.0003
565 KNEE OPERATION 3 0.0003
566 ASPERGILLUS INFECTION 2 0.0003
567 MIGRAINE 29 0.0003
568 BLOOD PRESSURE ABNORMAL 6 0.0003
569 BLOOD PRESSURE DECREASED 20 0.0003
570 URINARY RETENTION 10 0.0003
571 COUGH 84 0.0003
572 SPINAL FRACTURE 6 0.0003
573 BLOOD POTASSIUM DECREASED 9 0.0003
574 BLOOD UREA INCREASED 5 0.0003
575 QUALITY OF LIFE DECREASED 4 0.0003
576 VERTIGO 18 0.0003
577 BONE MARROW FAILURE 6 0.0003
578 SLUGGISHNESS 3 0.0003
579 ARTHRITIS 23 0.0003
580 MOBILITY DECREASED 21 0.0003
581 RIB FRACTURE 6 0.0003
582 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
583 SKELETAL INJURY 3 0.0003
584 PERITONITIS 6 0.0003
585 LOCALISED INFECTION 7 0.0003
586 VOMITING 136 0.0003
587 VENTRICULAR EXTRASYSTOLES 3 0.0003
588 EYE DISCHARGE 3 0.0003
589 SWELLING 27 0.0003
590 WHEEZING 17 0.0003
591 DERMATITIS 6 0.0003
592 NEUROTOXICITY 5 0.0003
593 GENERAL PHYSICAL HEALTH DETERIORATION 33 0.0003
594 HALLUCINATION, VISUAL 6 0.0003
595 BLINDNESS UNILATERAL 4 0.0003
596 OSTEOARTHRITIS 12 0.0003
597 RENAL PAIN 3 0.0003
598 LYMPHOPENIA 4 0.0003
599 RHEUMATOID ARTHRITIS 32 0.0003
600 IMPAIRED WORK ABILITY 6 0.0003
601 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
602 LIVER FUNCTION TEST INCREASED 6 0.0003
603 GASTROENTERITIS VIRAL 5 0.0003
604 FAECES DISCOLOURED 6 0.0003
605 HYPOKINESIA 4 0.0003
606 ASTHMA 31 0.0003
607 JOINT SWELLING 33 0.0003
608 SURGERY 16 0.0003
609 PNEUMONIA 88 0.0003
610 ANAPHYLACTIC REACTION 15 0.0003
611 PRODUCT USE IN UNAPPROVED INDICATION 67 0.0003
612 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
613 DIARRHOEA 174 0.0003
614 RENAL INJURY 8 0.0003
615 INFLUENZA 30 0.0003
616 WEIGHT DECREASED 75 0.0003
617 HEPATIC STEATOSIS 5 0.0003
618 INTESTINAL PERFORATION 3 0.0003
619 HYPOAESTHESIA ORAL 4 0.0003
620 IMPAIRED DRIVING ABILITY 3 0.0003
621 ACNE 20 0.0003
622 FOOT FRACTURE 5 0.0003
623 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
624 DERMATITIS CONTACT 3 0.0003
625 AORTIC ANEURYSM 2 0.0003
626 DECREASED APPETITE 61 0.0003
627 RENAL IMPAIRMENT 22 0.0003
628 PAIN IN EXTREMITY 77 0.0003
629 NASOPHARYNGITIS 48 0.0003
630 SEROTONIN SYNDROME 5 0.0003
631 THYROID DISORDER 4 0.0003
632 THROAT TIGHTNESS 7 0.0003
633 MADAROSIS 3 0.0003
634 MUSCULOSKELETAL CHEST PAIN 4 0.0003
635 CELLULITIS 13 0.0003
636 VASCULITIS 3 0.0003
637 PAIN 158 0.0003
638 ORAL HERPES 5 0.0003
639 INFECTION 37 0.0003
640 HYPOACUSIS 11 0.0003
641 NASAL CONGESTION 15 0.0003
642 AFFECTIVE DISORDER 2 0.0003
643 LYMPHADENOPATHY 9 0.0003
644 COVID-19 PNEUMONIA 3 0.0003
645 HEAD INJURY 8 0.0003
646 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
647 ILLNESS 26 0.0003
648 MYOCLONUS 3 0.0003
649 PREMATURE DELIVERY 4 0.0003
650 OBESITY 4 0.0003
651 HYPERLIPIDAEMIA 3 0.0003
652 SCIATICA 4 0.0003
653 ATRIAL FLUTTER 2 0.0003
654 WOUND 7 0.0003
655 WRIST FRACTURE 3 0.0003
656 PRODUCT ADMINISTRATION ERROR 5 0.0002
657 ASTHENIA 93 0.0002
658 NOCTURIA 3 0.0002
659 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
660 RESPIRATORY FAILURE 18 0.0002
661 NEURALGIA 6 0.0002
662 TASTE DISORDER 5 0.0002
663 BACK DISORDER 4 0.0002
664 PANCREATITIS 13 0.0002
665 DISCOMFORT 15 0.0002
666 RESPIRATORY DEPRESSION 3 0.0002
667 ENCEPHALOPATHY 6 0.0002
668 ABNORMAL FAECES 2 0.0002
669 METASTASES TO BONE 4 0.0002
670 MULTIPLE FRACTURES 4 0.0002
671 BLOOD PRESSURE INCREASED 37 0.0002
672 PRODUCT DOSE OMISSION ISSUE 71 0.0002
673 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
674 CYTOMEGALOVIRUS INFECTION 4 0.0002
675 NEEDLE ISSUE 7 0.0002
676 PNEUMONIA ASPIRATION 6 0.0002
677 HYPOTENSION 48 0.0002
678 ROAD TRAFFIC ACCIDENT 10 0.0002
679 HALLUCINATION 18 0.0002
680 BRAIN OEDEMA 3 0.0002
681 DYSPNOEA 134 0.0002
682 HEMIPARESIS 4 0.0002
683 RENAL FAILURE ACUTE 10 0.0002
684 HEPATIC ENZYME INCREASED 16 0.0002
685 JOINT INJURY 5 0.0002
686 INFUSION SITE PAIN 3 0.0002
687 UNRESPONSIVE TO STIMULI 6 0.0002
688 MUSCULOSKELETAL DISCOMFORT 4 0.0002
689 SKIN CANCER 5 0.0002
690 APHASIA 7 0.0002
691 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
692 CARDIAC ARREST 19 0.0002
693 NODULE 3 0.0002
694 OEDEMA PERIPHERAL 28 0.0002
695 TOOTH INFECTION 3 0.0002
696 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
697 MELAENA 5 0.0002
698 COLD SWEAT 4 0.0002
699 DRUG INTERACTION 36 0.0002
700 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
701 TOOTH DISORDER 5 0.0002
702 THIRST 4 0.0002
703 CHRONIC KIDNEY DISEASE 17 0.0002
704 RASH PAPULAR 5 0.0002
705 THROAT IRRITATION 10 0.0002
706 CONFUSIONAL STATE 36 0.0002
707 THERAPY NON-RESPONDER 10 0.0002
708 ANAL INCONTINENCE 2 0.0002
709 DRUG INEFFECTIVE 292 0.0002
710 ANXIETY 63 0.0002
711 OSTEOMYELITIS 4 0.0002
712 NEUROPATHY PERIPHERAL 21 0.0002
713 ACUTE HEPATIC FAILURE 3 0.0002
714 METABOLIC ACIDOSIS 7 0.0002
715 NAUSEA 173 0.0002
716 PERIPHERAL COLDNESS 3 0.0002
717 NIGHT SWEATS 7 0.0002
718 HEADACHE 136 0.0002
719 DIVERTICULITIS 6 0.0002
720 PERICARDIAL EFFUSION 5 0.0002
721 IRRITABILITY 13 0.0002
722 HYPERSENSITIVITY 40 0.0002
723 APHONIA 3 0.0002
724 MASS 3 0.0002
725 BACTERIAL INFECTION 4 0.0002
726 PERIPHERAL SWELLING 33 0.0002
727 COGNITIVE DISORDER 10 0.0002
728 APPENDICITIS 2 0.0002
729 PALPITATIONS 25 0.0002
730 HYPONATRAEMIA 12 0.0002
731 SKIN REACTION 3 0.0002
732 HEPATIC CIRRHOSIS 4 0.0002
733 HOT FLUSH 16 0.0002
734 GASTROINTESTINAL DISORDER 19 0.0002
735 SEASONAL ALLERGY 3 0.0002
736 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
737 FRACTURE 4 0.0002
738 SINUS TACHYCARDIA 3 0.0002
739 GASTRIC ULCER 4 0.0002
740 RASH ERYTHEMATOUS 10 0.0002
741 SOMNOLENCE 42 0.0002
742 INTERSTITIAL LUNG DISEASE 10 0.0002
743 LIVER FUNCTION TEST ABNORMAL 6 0.0002
744 DYSPHONIA 12 0.0002
745 PLASMA CELL MYELOMA 8 0.0002
746 NIGHTMARE 7 0.0002
747 DISABILITY 4 0.0002
748 SINUS DISORDER 4 0.0002
749 DISORIENTATION 8 0.0002
750 DELIRIUM 7 0.0002
751 HAEMORRHAGE INTRACRANIAL 3 0.0002
752 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
753 EPISTAXIS 15 0.0002
754 CYTOKINE RELEASE SYNDROME 4 0.0002
755 CONTUSION 19 0.0002
756 HAEMATEMESIS 5 0.0002
757 ABDOMINAL DISCOMFORT 33 0.0002
758 MUSCLE SPASMS 36 0.0002
759 TOXICITY TO VARIOUS AGENTS 33 0.0002
760 INSOMNIA 52 0.0002
761 ARTHRALGIA 81 0.0002
762 ANAPHYLACTIC SHOCK 5 0.0002
763 HYPOAESTHESIA 29 0.0002
764 DEPRESSION 44 0.0002
765 LUNG INFECTION 3 0.0002
766 TOOTH LOSS 4 0.0002
767 SPEECH DISORDER 10 0.0002
768 PRURITUS 72 0.0002
769 BODY HEIGHT DECREASED 2 0.0002
770 IRRITABLE BOWEL SYNDROME 4 0.0002
771 BURNING SENSATION 13 0.0002
772 MUSCLE TIGHTNESS 3 0.0002
773 BALANCE DISORDER 16 0.0002
774 PRURITUS GENERALISED 4 0.0002
775 CATARACT 11 0.0002
776 ABDOMINAL PAIN UPPER 38 0.0002
777 HYPERTENSION 39 0.0002
778 PRODUCT DISPENSING ERROR 4 0.0002
779 LUNG DISORDER 9 0.0002
780 PRODUCT PRESCRIBING ISSUE 4 0.0002
781 FALL 61 0.0002
782 CARDIAC DISORDER 17 0.0002
783 STOMATITIS 11 0.0002
784 DRUG LEVEL INCREASED 3 0.0002
785 RENAL FAILURE 24 0.0002
786 LIP SWELLING 6 0.0002
787 COAGULOPATHY 3 0.0002
788 MENTAL STATUS CHANGES 5 0.0002
789 ARTHROPATHY 10 0.0002
790 SKIN DISORDER 6 0.0002
791 FEELING COLD 5 0.0002
792 FEELING HOT 11 0.0002
793 ORAL PAIN 4 0.0002
794 FATIGUE 138 0.0002
795 HEART RATE IRREGULAR 4 0.0002
796 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
797 SCAR 3 0.0002
798 PARANOIA 3 0.0002
799 SHOCK 4 0.0002
800 DEVICE DEFECTIVE 3 0.0002
801 GAIT DISTURBANCE 33 0.0002
802 RASH MACULAR 6 0.0002
803 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
804 INFLUENZA LIKE ILLNESS 14 0.0002
805 SLEEP DISORDER 12 0.0002
806 ACUTE MYOCARDIAL INFARCTION 5 0.0002
807 PSYCHOTIC DISORDER 5 0.0002
808 URINARY INCONTINENCE 5 0.0002
809 BLOOD IRON DECREASED 2 0.0002
810 ATAXIA 2 0.0002
811 GALLBLADDER DISORDER 3 0.0002
812 POLLAKIURIA 7 0.0002
813 MYELOSUPPRESSION 6 0.0002
814 WHITE BLOOD CELL COUNT DECREASED 18 0.0002
815 MENTAL IMPAIRMENT 4 0.0002
816 MYALGIA 28 0.0002
817 BONE DISORDER 3 0.0002
818 PLEURAL EFFUSION 10 0.0002
819 ABDOMINAL DISTENSION 17 0.0002
820 DYSGEUSIA 12 0.0002
821 RASH 70 0.0002
822 DYSARTHRIA 6 0.0002
823 INTESTINAL OBSTRUCTION 6 0.0002
824 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
825 ABDOMINAL PAIN LOWER 4 0.0002
826 MOOD SWINGS 5 0.0002
827 TREMOR 26 0.0002
828 HERPES ZOSTER 9 0.0002
829 LETHARGY 9 0.0002
830 PULMONARY FIBROSIS 3 0.0002
831 GLAUCOMA 3 0.0002
832 PRESCRIBED OVERDOSE 3 0.0002
833 DYSTONIA 3 0.0002
834 BONE PAIN 9 0.0002
835 SWELLING FACE 10 0.0002
836 IMPAIRED HEALING 5 0.0002
837 OSTEONECROSIS 5 0.0002
838 UPPER LIMB FRACTURE 3 0.0002
839 PRESCRIBED UNDERDOSE 3 0.0002
840 RENAL DISORDER 7 0.0002
841 PLATELET COUNT DECREASED 16 0.0001
842 ABORTION SPONTANEOUS 6 0.0001
843 FULL BLOOD COUNT DECREASED 3 0.0001
844 FEAR 4 0.0001
845 MUSCULOSKELETAL STIFFNESS 13 0.0001
846 DISTURBANCE IN ATTENTION 8 0.0001
847 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
848 OCULAR HYPERAEMIA 7 0.0001
849 DYSPHAGIA 14 0.0001
850 WEIGHT INCREASED 33 0.0001
851 PULMONARY EMBOLISM 14 0.0001
852 TREATMENT NONCOMPLIANCE 8 0.0001
853 DRUG ABUSE 12 0.0001
854 RHABDOMYOLYSIS 6 0.0001
855 HAEMOPTYSIS 4 0.0001
856 WITHDRAWAL SYNDROME 6 0.0001
857 BLOOD TEST ABNORMAL 2 0.0001
858 RED BLOOD CELL COUNT DECREASED 4 0.0001
859 HYPERSOMNIA 4 0.0001
860 SEIZURE 16 0.0001
861 MENTAL DISORDER 6 0.0001
862 CRYING 5 0.0001
863 CHEST DISCOMFORT 14 0.0001
864 MALIGNANT NEOPLASM PROGRESSION 14 0.0001
865 THERAPY CESSATION 7 0.0001
866 HAEMOGLOBIN DECREASED 14 0.0001
867 LABORATORY TEST ABNORMAL 4 0.0001
868 HAEMORRHAGE 14 0.0001
869 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
870 THERAPEUTIC RESPONSE DECREASED 8 0.0001
871 MUSCLE TWITCHING 3 0.0001
872 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
873 ACUTE MYELOID LEUKAEMIA 2 0.0001
874 NERVOUS SYSTEM DISORDER 4 0.0001
875 SWOLLEN TONGUE 4 0.0001
876 PRODUCT USE ISSUE 24 0.0001
877 ARRHYTHMIA 6 0.0001
878 DIZZINESS 63 0.0001
879 PRODUCT PRESCRIBING ERROR 3 0.0001
880 ABSCESS 2 0.0001
881 BLISTER 7 0.0001
882 CARDIAC FAILURE 10 0.0001
883 EYE PAIN 7 0.0001
884 MUSCULAR WEAKNESS 14 0.0001
885 LIVER INJURY 3 0.0001
886 OSTEONECROSIS OF JAW 3 0.0001
887 DRY EYE 6 0.0001
888 TYPE 2 DIABETES MELLITUS 4 0.0001
889 CEREBROVASCULAR ACCIDENT 20 0.0001
890 HEPATITIS 3 0.0001
891 HOSPITALISATION 18 0.0001
892 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
893 SKIN ULCER 3 0.0001
894 RASH GENERALISED 3 0.0001
895 ILL-DEFINED DISORDER 7 0.0001
896 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
897 PARAESTHESIA 18 0.0001
898 INTENTIONAL PRODUCT MISUSE 10 0.0001
899 HYPOXIA 4 0.0001
900 LIVER DISORDER 5 0.0001
901 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
902 CEREBRAL HAEMORRHAGE 4 0.0001
903 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
904 SYNCOPE 11 0.0001
905 RESTLESSNESS 4 0.0001
906 LOSS OF CONSCIOUSNESS 14 0.0001
907 SUICIDAL IDEATION 10 0.0001
908 AGITATION 8 0.0001
909 FEELING ABNORMAL 26 0.0001
910 BLOOD GLUCOSE ABNORMAL 2 0.0001
911 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
912 AMNESIA 7 0.0001
913 HEPATIC FUNCTION ABNORMAL 4 0.0001
914 BLOOD SODIUM DECREASED 2 0.0001
915 UNEVALUABLE EVENT 8 0.0001
916 BLOOD URINE PRESENT 2 0.0001
917 INCORRECT DOSE ADMINISTERED 24 0.0001
918 DIABETES MELLITUS 8 0.0001
919 MULTIPLE SCLEROSIS 5 0.0001
920 VISION BLURRED 14 0.0001
921 MEMORY IMPAIRMENT 14 0.0001
922 ABNORMAL BEHAVIOUR 4 0.0001
923 HYPERHIDROSIS 13 0.0001
924 THROMBOSIS 8 0.0001
925 DRY MOUTH 8 0.0001
926 FLUID RETENTION 5 0.0001
927 BODY TEMPERATURE INCREASED 2 0.0001
928 THERAPY INTERRUPTED 7 0.0001
929 ALOPECIA 19 0.0001
930 COMPLETED SUICIDE 8 0.0001
931 CARDIO-RESPIRATORY ARREST 4 0.0001
932 ECZEMA 5 0.0001
933 MUSCULOSKELETAL PAIN 5 0.0001
934 HIP FRACTURE 3 0.0001
935 DEEP VEIN THROMBOSIS 6 0.0001
936 RASH PRURITIC 5 0.0001
937 FLATULENCE 5 0.0001
938 APPLICATION SITE PRURITUS 2 0.0001
939 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
940 ADVERSE EVENT 8 0.0001
941 SKIN EXFOLIATION 7 0.0001
942 INJECTION SITE MASS 3 0.0001
943 VISUAL IMPAIRMENT 10 0.0001
944 EYE SWELLING 3 0.0001
945 MYOCARDIAL INFARCTION 14 0.0001
946 FLUSHING 8 0.0001
947 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
948 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
949 APPLICATION SITE ERYTHEMA 2 0.0001
950 DEPRESSED MOOD 4 0.0001
951 INJECTION SITE HAEMORRHAGE 6 0.0001
952 DRY SKIN 10 0.0001
953 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
954 LUNG NEOPLASM MALIGNANT 3 0.0001
955 MEDICATION ERROR 4 0.0001
956 ATRIAL FIBRILLATION 7 0.0001
957 CONVULSION 4 0.0001
958 ANGINA PECTORIS 2 0.0001
959 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
960 DEVICE LEAKAGE 3 0.0001
961 VAGINAL HAEMORRHAGE 3 0.0001
962 UNDERDOSE 5 0.0001
963 PULMONARY OEDEMA 3 0.0001
964 NO ADVERSE EVENT 12 0.0001
965 SUICIDE ATTEMPT 4 0.0001
966 TINNITUS 3 0.0001
967 SKIN DISCOLOURATION 3 0.0001
968 INJECTION SITE PAIN 20 0.0001
969 INJECTION SITE ERYTHEMA 8 0.0001
970 BLOOD CHOLESTEROL INCREASED 3 0.0001
971 BLOOD GLUCOSE DECREASED 3 0.0001
972 INJECTION SITE PRURITUS 4 0.0001
973 ANGER 2 0.0001
974 INJECTION SITE REACTION 4 0.0001
975 NERVOUSNESS 3 0.0001
976 INJURY 4 0.0001
977 DERMATITIS ATOPIC 3 0.0001
978 OVERDOSE 12 0.0001
979 ACCIDENTAL OVERDOSE 2 0.0001
980 BLOOD GLUCOSE INCREASED 10 0.0001
981 DEATH 45 0.0001
982 INJECTION SITE SWELLING 4 0.0001
983 PRODUCT SUBSTITUTION ISSUE 3 0.0001
984 BLINDNESS 2 0.0000
985 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
986 INTENTIONAL OVERDOSE 3 0.0000
987 NEOPLASM MALIGNANT 3 0.0000
988 DEVICE MALFUNCTION 3 0.0000
989 CARDIAC FAILURE CONGESTIVE 3 0.0000
990 DRUG WITHDRAWAL SYNDROME 3 0.0000
991 ADVERSE DRUG REACTION 3 0.0000
992 DRUG DEPENDENCE 5 0.0000